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Intestinal multidrug resistance-associated protein 2 is an ABC transporter that 
limits the absorption of xenobiotics ingested orally, thus acting as essential component 
of the intestinal biochemical barrier. Metabolic Syndrome (MetS) is a pathological 
condition characterized by dyslipidemia, hyperinsulinemia, insulin resistance, chronic 
inflammation, and oxidative stress (OS). In a previous study we demonstrated that 
MetS-like conditions induced by fructose in drinking water (10% v/v, during 21 days), 
significantly reduced the expression and activity of intestinal Mrp2 in rats. We here 
evaluated the potential beneficial effect of geraniol or vitamin C supplementation, 
natural compounds with anti-inflammatory and anti-oxidant properties, in reverse 
fructose-induced Mrp2 alterations. After MetS-like conditions were induced (21 days), 
animals were cotreated with geraniol or vitamin C or vehicle for another 14 days. 
Decreased expression of Mrp2 protein and mRNA due to fructose administration was 
reversed by geraniol and by vitamin C, consistent with restoration of Mrp2 activity 
evaluated in everted intestinal sacs. Concomitantly, increased intestinal IL-1β and IL-6 
levels induced by fructose were totally and partially counterbalanced, respectively, by 
geraniol administration. The intestinal redox unbalance generated by fructose was 
improved by geraniol and vitamin C, as evidenced by decreasing lipid peroxidation 
products and activity of Superoxide Dismutase and by normalizing glutathione 
reduced/oxidized glutathione ratio. The restoration effects exhibited by geraniol and 
vitamin C suggest that local inflammatory response and OS generated under MetS-like 
conditions represent important mediators of the intestinal Mrp2 down-regulation. 
Additionally, both agents could be considered of potential therapeutic value to preserve 
Mrp2 function under MetS conditions 
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Abbreviations: ABC, ATP-Binding Cassette; AUC, area under the curve; BBM, brush 
border membrane; b.wt., body weight; CAT, Catalase; CDNB, 1-chloro-2,4-
dinitrobenzene; C, control; DNP-SG, dinitrophenyl-S-glutathione; GSH, reduced 
















ITT, insulin tolerance test; HOMA, homoeostasis model assessment; IL-1β, Interleukin-
1β; IL-6, Interleukin-6; IR, insulin resistance; LPO, lipid peroxidation; Mrp2, multidrug 
resistance-associated protein 2; OS, oxidative stress; SOD, Superoxide Dismutase; 



































Metabolic syndrome (MetS) is a contemporary condition defined by a cluster of 
physiological interconnected biochemical, clinical, and metabolic factors consisting of 
elevated blood pressure, hypertriglyceridemia, reduced serum high-density lipoprotein- 
cholesterol, glucose intolerance, hyperinsulinemia, and insulin resistance. These factors 
increase the risk of individuals to develop cardiovascular disease and Type 2 Diabetes 
[1-3]. MetS and its associated complications have become one of major health problems 
worldwide, with an increase incidence due to improper nutrition and sedentary lifestyle 
[4]. In the last decades a marked increase in average fructose intake in the way of 
sweeteners used by food industry has been documented [5]; at the same time, there is 
growing evidence indicating that excessive fructose consumption is causally linked to 
MetS prevalence [6-8]. Rats fed with a fructose-rich diet constitute a valid model of 
diet-induced insulin resistance, associated with hyperinsulinemia, glucose intolerance, 
hypertriglyceridemia, as well as inflammation and oxidative stress (OS) in different 
tissues [9-11]. Although the precise molecular mechanism by which fructose-rich diet 
induces MetS remains in discussion, it has been postulated that an increase in OS plays 
a key role in its pathogenesis and subsequent complications [12-14]. In support to this 
assumption, epidemiologic studies show that anti-oxidants (e.g., vitamin A, C, and E) 
are associated with reduced risk of MetS [15,16], consistent with their effects in 
reducing main alterations induced by fructose-rich diet [17,18].  
Interestingly, high fructose consumption correlates with increased intestinal 
permeability, as a significant component of fructose-induced MetS [19,20]. 
Consumption of fructose raises fructokinase-C expression in small intestine [21]; 
consequently, the acceleration of intestinal fructolysis originates local OS and 
inflammation and reduces the expression of relevant tight junction proteins, ultimately 
resulting in increased paracellular permeability [22]. Regarding the transcellular 
component of intestinal barrier function, we have recently reported a significant 
reduction in Multidrug resistance protein 2 (Mrp2, ABCC2) expression in normal rats 
fed with a fructose-rich diet for 21 days [23], resulting in impaired activity and 
consequently, increased absorption of Mrp2 substrates. Mrp2 is a drug efflux pump 
belonging to the ATP-Binding Cassette (ABC) transporter superfamily and is 
constitutively expressed in the apical membrane of enterocytes, mainly from proximal 
















of food contaminants and drugs incorporated orally [24, 25]. Thus, any alteration in the 
intestinal Mrp2 activity will increase the toxicity of xenobiotics as well as it will affect 
the bioavailability and eventually the safety of therapeutic drugs. 
The specific mechanisms underlying the reduction of intestinal Mrp2 under MetS 
conditions are still unknown. However, it is tempting to speculate that OS and 
inflammation may play a significant role as they occurred in simultaneous with Mrp2 
down-regulation induced by fructose administration [26]. Both factors were previously 
shown to be important regulators of Mrp2 expression under other experimental 
pathological conditions such as LPS-induced endotoxemia and obstructive cholestasis 
[27-29]. Therefore, administration of anti-oxidant and anti-inflammatory agents to rats 
with MetS could be a useful tool to support our hypothesis. Geraniol, is an important 
monoterpene alcohol naturally found in the essential oils of lemon, rose, ginger, orange, 
among others [30]. Pharmacological studies involving geraniol have shown that it 
possesses potent anti-oxidant and anti-inflammatory properties [31, 32]. While the 
antidiabetic, anti-oxidant and anti-inflammatory effect of this monoterpene in 
experimental MetS-rats model has previously been well documented [33], studies 
regarding its efficacy in reversing intestinal Mrp2 alterations have not been performed 
until the present. 
On the other hand, given that OS has a central role in the etiology of MetS and that 
MetS patients have a deficient endogenous anti-oxidant capacity [34], it was also our 
interest to evaluate the effect of vitamin C on Mrp2 down-regulation in our 
experimental model of MetS. Vitamin C constitutes an important non-enzymatic anti-
oxidative defense and its supplementation was proven effective to decrease the 
incidence of MetS in patients [35, 36]. Accordingly, the aim of this study was to 
validate the efficacy of geraniol (as anti-oxidant and anti-inflammatory agent) and 
vitamin C (as anti-oxidant agent) in revert intestinal Mrp2 down-regulation in an insulin 
resistant rat model that mimics aspects of MetS, with the final purpose of identifying the 
















2. MATERIALS AND METHODS 
2.1. Chemicals 
Fructose was obtained from Laboratorio Cicarelli (Bs. As, Argentina). Geraniol, 
vitamin C, leupeptin, phenylmethylsulfonyl fluoride, pepstatin A, 3-isobutyl-1-
methylxanthine, glutathione, dithiothreitol, 1-chloro-2,4-dinitrobenzene (CDNB), 2-
thiobarbituric acid, nitroblue tetrazolium, and hydrogen peroxide (H2O2) were obtained 
from Sigma-Aldrich (St. Louis, USA). 2-vinylpyridine was obtained from Fluka 
Chemical Corp (Milwaukee, USA). All other chemicals and reagents used were 
commercial products of analytical-grade purity. 
 
2.2. Animals and treatments 
Adult male Wistar rats (220–250 g b.wt.; 70-day old) were purchased from 
Centro de Medicina Comparada-Instituto de Cs. Veterinarias del Litoral (UNL-
CONICET, Esperanza, Argentina). Animals received standard commercial diet ad 
libitum and either tap water (C group), or tap water with 10% (w/v) fructose (FRU 
group), for 21 days to induce MetS-like conditions [23,36,37] (Fig.1). Animals were 
grouped (two animals per cage) and kept under controlled conditions (23 ± 2°C) with a 
fixed 12-h light–dark cycle (06:00–18:00 h). Installation of MetS was verified by 
plasma TAG (triacylglycerol) and immunoreactive insulin levels and by the 
intraperitoneal glucose tolerance test (IPGTT) (data not shown). At day 21, either MetS 
or control rats were randomly divided into 8 subgroups as shown in Fig. 1: four groups 
belonging to the protocol of reversion by geraniol and four groups belonging to the 
protocol of reversion by vitamin C. In the first protocol (Fig. 1A), control and MetS rats 
were daily administered with 1% Tween 80 (C and FRU groups) or geraniol in 1% 
Tween 80 (250 mg/kg/day, p.o [37]; GO and FRU+GO groups). In the second protocol 
(Fig. 1B), control and MetS rats were daily administered with tap water (C and FRU 
groups) or with vitamin C (100 mg/kg/day, p.o [38]; VitC and FRU+VitC groups). 
Rats of all experimental groups were subjected to the IPGTT and to the insulin 
tolerance test (ITT) at the end of the treatments, after overnight and 6 hours fasting 
respectively. Liquid intake was monitored every other day and body weight once a week 
throughout the treatment. Total drinking volume of animals housed together was 
averaged and considered as a single data. All the experimental protocols were 
















(Expedient 6109/012 E.C. Resolution 267/02) and were approved by the Institutional 
Animal Use Committee of the National University of Rosario, Argentina. 
 
2.3. Specimen collection 
Animals were fasted 12 h before sacrifice, performed under intraperitoneal 
anesthesia [ketamine: 100 mg (0.42 mmol)/kg b.wt.; xylazine: 15 mg (0.07 mmol)/kg 
b.wt.] between 08:00 and 09:00 h. After an abdominal incision, blood samples were 
taken through cardiac puncture and placed into heparinized tubes to measure plasma 
glucose, triacylglycerol (TAG) and immunoreactive insulin levels. For collection of 
jejunum specimens, the first 15 cm starting from the pyloric valve and corresponding to 
the duodenum were excluded and the following 30 cm were taken and considered as the 
proximal jejunum. This segment was carefully rinsed with ice-cold saline and dried with 
filter paper. For western blot studies, the jejunum was immediately opened lengthwise, 
the mucus layer was carefully removed, and the mucosa was obtained by scraping, 
weighed, and used for brush border membrane (BBM) preparation. For total RNA 
isolation, small rings were cut from this same region of the intestine, frozen in liquid 
nitrogen and kept at -70°C until isolation by using TRIzol reagent (Invitrogen, Carlsbad, 
USA) following the manufacturer’s protocol. For Mrp2 transport studies in vitro, 3-cm 
segments of the proximal jejunum were immediately used in preparation of everted 
sacs. Aliquots of proximal jejunum were homogenized in saline (1:2) for assessment of 
glutathione content, lipid peroxidation and anti-oxidant enzyme activities, or in 
phosphate-buffered saline (pH: 7.40) (1:2) for assessment of IL-1β and IL-6 when it 
corresponds.  
 
2.4. Biochemical assays 
Plasma glucose and TAG levels were determined spectrophotometrically using 
commercial kits (Wiener Laboratorios, Rosario, Argentina). Plasma insulin levels were 
measured by RIA using a commercial kit (Rat insulin, Millipore Corporation, Billerica, 
USA). 
The IPGTT was performed 3 days before the animals were sacrificed as 
described previously [23]. For the calculation of the area under the curve (AUC) the 
















For the ITT, 2 days before the experiments, the rats were fasted for 6 hours and 
then a blood sample was taken from the tail vein (basal glycemia, 0 min). The animals 
were immediately injected i.p. with 0.75 units/kg human recombinant insulin (Denver 
Farma S.A, Buenos Aires, Argentina) [39] and additional blood samples were taken at 
30, 60, and 90 min also from the tail vein. For the calculation of the area under the 
curve (AUC) the GraphPad Prism 5 software was used and the values were expressed in 
mM/90 min. 
Serum insulin and fasting blood glucose values were used to estimate IR (insulin 
resistance) by HOMA (homoeostatic model assessment)-IR index, using the equation: 
serum insulin (µUI/ml)×fasting blood glucose (mmol/l)/22.5 [40]. When the value of 
HOMA-IR increases, IR augments, thus indicating a decrease in insulin sensitivity. 
 
2.5. Western blot studies 
BBM were prepared from mucosa samples as described previously [24]. Protein 
concentration was measured by using bovine serum albumin as standard [41]. Aliquots 
of the BBM preparations were kept on ice and used the same day in western blot 
studies. Mrp2 was detected in BBMs as described previously [24]. Equal loading and 
transference of protein was systematically checked by both detection of β-actin and 
staining of the membranes with Ponceau S. Primary antibodies used were anti-MRP2 
(M2 III-6, Alexis Laboratories, San Diego, USA) and anti-β-actin (A-2228, Sigma–
Aldrich). Immunoreactive bands were quantified with Gel-Pro Analyzer software 
(Media Cybernetics, Inc., Bethesda, USA). 
 
2.6. Real-Time Polymerase Chain Reaction (PCR) studies 
Quantitative real-time PCR studies of ABCC2 mRNA were performed as 
described previously [42] using the following primer pairs: forward, 5’-
accttccacgtagtgatcct-3’ and reverse, 5’-acctgctaagatggacggtc-3 for ABCC2 and forward, 
5’-gtaacccgttgaaccccatt-3’ and reverse, 5’-ccatccaatcggtagtagcg-3’ for 18S rRNA 
(housekeeping gene). 
 
2.7. Assessment of Mrp2 activity in vitro 
To characterize the effect of the different treatments on intestinal Mrp2 efflux 
















proximal jejunum, were incubated for 30 min in the presence of 100 µM CDNB in the 
mucosal compartment as described previously [43]. After diffusion of CDNB into the 
enterocyte, and further endogenous conjugation with glutathione, the product 
dinitrophenyl-S-glutathione (DNP-SG) was detected by high-performance liquid 
chromatography in the same mucosal compartment as described [43].  
 
2.8. Determination of intestinal glutathione content and lipid peroxidation 
(LPO) 
Total glutathione [reduced (GSH) + oxidized (GSSG)] and GSSG were assessed 
as described previously [44], in supernatants of proximal jejunum homogenates 
prepared as it was previously described [23]. GSH values were determined from total 
glutathione and GSSG concentrations and oxidative stress index was calculated from 
the GSH/GSSG ratio and expressed as % of controls. 
LPO was estimated by measuring thiobarbituric acid reactive substances 
(TBARS) using the procedure of Ohkawa et al. [45] in intestinal homogenates as 
described previously [23].  
 
2.9. Assessment of anti-oxidant enzyme activities 
Enzyme activities were assessed in supernatants of jejunum homogenates 
prepared as was previously described [23]. Protein concentration was measured by 
using bovine serum albumin as standard [41]. Superoxide Dismutase (SOD) assay was 
based on the method of Beauchchamp and Fridovich [46] with modifications of 
Donahue et al. [47], which measures the SOD inhibition of photochemical reduction of 
nitroblue tetrazolium. Catalase (CAT) activity was determined by monitoring the rate of 
decomposition of H2O2 as a function of decrease in absorbance at 240 nm for 2 min 
[48]. Both enzyme activities were expressed as % of controls. 
 
2.10. Assessment of interleukins  
IL-1β and IL-6 levels were determined in jejunum homogenates as described 
previously [23] and expressed as % of controls. 
 
















Data are presented as mean ± S.D. All statistical analyses were performed using 

















3 RESULTS  
3.1. Protocol of reversion by geraniol administration 
3.1.1. Effect of geraniol on body weight and food/water intake 
Following 35 days of treatment, body weight gain did not differ among the 
different experimental groups (93±21, 111±11, 93±9, 96±21 g for C, FRU, GO and 
FRU+GO, respectively). Liquid consumption was higher for FRU animals than for C 
(50.23±0.64 vs. 38.00±0.04 ml/day, respectively; P<0.05), whereas coadministration of 
geraniol did not change water intake respect to administration of fructose alone 
(46.72±4.90 vs. 50.23±0.64 ml/day for FRU+GO and FRU, respectively). Food intake 
was significantly lower in FRU, GO and FRU+GO groups respect to C (15.23±0.27, 
16.31±0.50 and 14.70±0.27 vs 22.20±0.72 g/day, respectively; P<0.05). In contrast, 
calories consumption was significantly higher in FRU and FRU+GO groups respect to 
C and GO groups (47.20±0.90 and 44.80±0.90 vs 39.50±5.40 and 29.04±0.90 kcal/day, 
respectively; P<0.05). 
 
3.1.2. Effect of geraniol on altered glucose homeostasis and plasma TAG level 
induced by fructose administration 
Plasma biochemical determinations as well as IPGTT and ITT curves of 
experimental groups are shown in Table 1 and in Figure 2, respectively. Concerning the 
fasting level of blood glucose, there were no significant differences among the four 
groups studied (Table 1). However, FRU group displayed an impaired glucose tolerance 
as indicated by increased AUC value in the IPGTT measure (Fig. 2A). ITT analysis also 
revealed an impaired insulin sensitivity in FRU vs. C rats (a greater AUC value, Fig. 
2B), which together with elevated fasting insulin levels and HOMA-IR index indicated 
the establishment of IR in these rats. Treatment with geraniol significantly improved the 
response to glucose overload and insulin administration and restored the HOMA-IR 
index in fructose fed rats as well, consistent with reversion of the IR condition (Table 
1). Also, the increase of TAG plasma levels induced by fructose administration, were 
completely reverted by coadministration with geraniol (Table 1).  
 

















Figure 3A shows that Mrp2 expression, detected in BBM, was significantly 
decreased in FRU group with respect to C (77% decrease), as we previously described 
[26]. Cotreatment with geraniol was able to reverse Mrp2 down-regulation to the extent 
that densitometry revealed no difference with respect to C (Fig. 3A). Geraniol 
administered alone did not affect Mrp2 expression with respect to control rats. 
We performed real-time PCR studies to evaluate the involvement of a 
transcriptional mechanism and found that fructose administration indeed reduced 
ABCC2 mRNA levels respect to C (40% decrease) and that geraniol reverted such effect 
(Fig. 3B). 
Mrp2 activity was evaluated by the luminal secretion of DNP-SG, a typical Mrp2 
substrate, using the in vitro model of everted intestinal sacs. Consistent with western 
blot studies, the amount of DNP-SG accumulated in the mucosal compartment 
decreased in FRU group with respect to C (43% decrease) and returned to the normal 
value in the cotreated group (Fig. 3C). 
 
3.1.4.  Effect of geraniol on altered intestinal redox balance and anti-oxidant 
defenses induced by fructose administration 
To evaluate the anti-oxidant properties of geraniol, we tested GSH/GSSG ratio 
and TBARS levels. Figure 4A shows that reduction of the GSH/GSSG ratio induced by 
fructose (38% decrease) was completely restored by cotreatment with geraniol. At the 
same time, GSSG intestinal content was increased in FRU group (58% increase) and 
preserved in FRU+GO when compared to C, while GSH content remained unchanged 
irrespective of the treatment (data not shown). Fructose administration increased 
TBARS levels respect to C (60% increase), whereas geraniol coadministration lowered 
such measure under control value (27% decrease) (Fig. 4B). Also, cotreatment with 
geraniol counteracted the increase in SOD activity observed for FRU group (61% 
increase) (Fig. 4C), whereas CAT activity did not vary among the different 
experimental groups (Fig. 4D). Geraniol administration alone did not affect GSH/GSSG 
ratio, TBARS levels or SOD activity. 
 
3.1.5.  Effect of geraniol on increased intestinal proinflammatory cytokine levels 
















Panels A and B from Figure 5 show that both IL-1β and IL-6 levels increased 
significantly in proximal jejunum from FRU group when compared to control group 
(58% and 123% increases, respectively). Cotreatment with geraniol completely restored 
IL-1β levels and only partially those of IL-6. 
 
3.2. Protocol of reversion by vitamin C administration 
3.2.1.  Effect of vitamin C on body weight and food/water intake 
After 35 days of treatment, body weight gain did not differ between 
experimental groups (83±8, 87±3, 77±9 and 87±3 g for C, FRU, VitC and FRU+VitC, 
respectively). Liquid consumption was higher for FRU animals than for C (55.60±1.30 
vs. 34.40±1.70 ml/day, respectively; P<0.05), whereas this measure was similar 
between FRU+VitC and FRU groups (54.08±6.50 vs. 55.60±1.30 ml/day, respectively). 
Food consumption was significantly lower in FRU group respect to C (22.33±1.82 vs. 
26.07±0.50 g/day, respectively; P<0.05), while in FRU+ VitC group this parameter 
remained unchanged respect to FRU group (22.25±1.13 vs. 22.33±1.82g/day, 
respectively). Calories consumption were significantly higher in FRU and FRU+VitC 
groups respect to C and VitC groups (46.01±2.80 and 45.50±0.43 vs 40.12±0.60 and 
41.25±0.35 kcal/day, respectively; P<0.05).  
 
3.2.2.  Effect of vitamin C on altered glucose homeostasis and plasma TAG levels 
induced by fructose administration 
Biochemical measures are shown in Table 2. There were no significant 
differences in basal blood glucose levels among groups. Plasma TAG and insulin levels 
were significantly increased by fructose administration and completely reverted by 
vitamin C. In addition, key parameters of glucose homeostasis were assessed in all 
experimental groups and are shown in Figure 6. The highest glycemia levels in the 
IPGTT and ITT curves (Fig. 6), demonstrated by a significantly elevated AUC values 
(inserts in Fig. 6), as well as in the HOMA-IR value (Table 2) found in FRU group 
confirmed development of IR. Rats that underwent vitamin C cotreatment demonstrated 
better glucose tolerance (Fig. 6A and Table 2) and insulin sensitivity (Fig. 6B) than 
those receiving only fructose. Cotreatment with vitamin C also normalized the altered 
insulin sensitivity index (Table 2), whereas administration with vitamin C alone did not 

















3.2.3.  Effect of vitamin C on Mrp2 down-regulation induced by fructose 
administration 
Fructose administration caused a significant decrease in Mrp2 protein expression 
with respect to C (75% decrease) in proximal jejunum. However, the decreased levels of 
Mrp2 protein were significantly attenuated in rats cotreated with vitamin C (Fig. 7A). 
Likewise, detection of mRNA levels revealed that fructose administration decreased 
Mrp2 expression with respect to C (56% decrease), whereas this measure returned to 
normal values in the FRU+ VitC group (Fig. 7B). Figure 7C shows that variations in 
Mrp2 activity in response to fructose and/or vitamin C administration were consistent 
with those of mRNA, indicating a 42% decrease in FRU group respect to C and 
restoration under cotreatment conditions. Vitamin C administered alone did not affect 
Mrp2 expression or activity with respect to control rats. 
 
3.2.4. Effect of vitamin C on altered intestinal redox balance and anti-oxidant 
defenses induced by fructose administration 
Figure 8A shows that reduction of the GSH/GSSG ratio induced by fructose 
(36% decrease) was completely restored by cotreatment with vitamin C. At the same 
time, GSSG intestinal content was higher in FRU group (60% increase) and was 
normalized in FRU+VitC as compared to C, while GSH content remained unchanged 
(data not shown). Similarly, the increase of TBARS levels induced by fructose (65% 
increase) returned to normal value after vitamin C administration, as shown in Figure 
8B. Regarding the anti-oxidant defense, SOD activity was increased in FRU group 
(63% increase) and restored in FRU+VitC rats (Fig. 8C). CAT activity was not affected 
by fructose administration but significantly reduced in both VitC and FRU+VitC groups 

















Fructose is a sugar widely found in natural foods, as fruits and vegetables, and is 
also used as a supplement in a variety of processed foods. Excessive fructose 
consumption is an important risk factor contributing to development of MetS, with 
associated dysfunctions in multiple tissues and organs including liver, adipose, 
pancreatic islet, skeletal muscle and intestine, among others [49, 50]. Although the 
exact pathogenesis of MetS is still under debate, it is firmly postulated that primary 
metabolites of fructose, produced in organs where fructokinase-C is expressed, play a 
central role initially inducing systemic and local insulin resistance, as well as triggering 
overproduction of reactive oxygen species. These primary alterations subsequently lead 
to exacerbated secretion of inflammatory cytokines, adiponectin, endotoxin and leptin, 
which cause systemic or local inflammation response, lipid accumulation, and 
endothelial dysfunction, in addition to hyperphagia [50]. Clearly, OS is a key event 
contributing to the etiopathogenesis of MetS. 
Evidence from animal models as well as human studies indicate that insulin 
resistance associated with overconsumption of fructose induces important alterations in 
the intestinal mucosa, possibly due to fructose metabolism in the intestinal wall since 
this tissue also expresses fructokinase-C [51, 21]. Some of these alterations are 
increased intestinal permeability, consequence of local inflammation and reduction of 
expression of tight junction proteins such as occludin and zone occludes-1 [52]. In line 
with this, we recently demonstrated a significant down-regulation of the drug 
transporter Mrp2 in proximal jejunum of fructose-fed rats, not associated with erosive 
alterations of the intestinal epithelium, but rather with a specific regulation, at least in 
part, at transcriptional level [23]. Interestingly, such regulation occurred in parallel with 
alteration of the redox balance and increased inflammatory response in intestinal tissue 
[23]. Down-regulation of Mrp2 protein by the systemic pro-inflammatory cytokine IL-
1 was previously observed in the duodenum of extrahepatic cholestasic rats, with 
concomitant reduction of its mRNA levels resulting from its transcriptional regulation 
[28]. Similarly, IL-1 appears to be the major regulator of Mrp2 expression under 
endotoxemic conditions, since its blockade led to a complete preservation of the 
transporter expression (protein and mRNA) [53]. On the other hand, exposure to OS 
was found to produce a marked decrease in hepatic Mrp2 protein expression, mainly 
















main mediator of inflammatory response) and/or OS mediate down-regulation of 
intestinal Mrp2 under MetS conditions induced by fructose administration. In order to 
confirm this supposition, we evaluated the effect of coadministration with geraniol or 
vitamin C. 
Geraniol is an acyclic monoterpene alcohol found in medicinal plants and used 
traditionally for several medical purposes including diabetes [55]. Geraniol possesses 
pharmacological effects such as anti-oxidant, anticancer and anti-inflammatory 
properties [56,57,58]. Under the present experimental conditions, geraniol per se did not 
affect body weight gain, plasma glucose, TGA or insulin levels. However, under MetS-
like conditions, geraniol reduced plasma TGA levels to normal values and also restored 
insulin sensitivity, indicated by reduction of HOMA-IR index and by a better response 
to both the ITT and IPGTT, as was previously reported [32]. As expected, OS indicators 
were also reversed by geraniol supplementation, agreeing well with previous studies 
demonstrating the anti-oxidant potential of geraniol in vivo [59]. Similarly, geraniol 
totally counteracted the increase in IL-1β production and partially neutralized the 
increase of IL-6 induced by fructose administration, consistent with its anti-
inflammatory action. More importantly, geraniol treatment totally reversed loss of Mrp2 
expression and activity. A direct action of geraniol on expression of Mrp2 seems 
unlikely since GO group exhibited similar levels of protein and mRNA when compared 
to control rats. Therefore, it is possible to postulate that the modulation of both OS and 
inflammatory response by geraniol contributed to ameliorate Mrp2 down-regulation 
under MetS conditions. 
Vitamin C is a recognized natural anti-oxidant of therapeutic application [15]. 
Our data indicate that vitamin C restored the intestinal redox unbalance induced by 
fructose, as evidenced by reduction of LPO and concomitant normalization of 
GSH/GSSG ratio and SOD activity. Catalase activity was reduced in both VitC and 
FRU+VitC groups respect to control rats. This is likely due to formation of 
semidehydroascorbate, an intermediate in vitamin C oxidation, which exhibits 
inhibitory action on catalase activity [60]. Our results demonstrate for the first time that 
administration of vitamin C alleviates MetS in rat model, essentially by reducing insulin 
resistance, as demonstrated by reduction of HOMA-IR index as well as by a better 
response to both the ITT and IPGTT. This is in accordance with previous 
















associated with lower risk of MetS in women and that MetS patients had considerably 
lower plasma levels of vitamin A, C and E compared to healthy subjects [35,16]. 
Significantly, vitamin C administration was also able to reverse intestinal Mrp2 down-
regulation, restoring its activity as well as protein and mRNA levels. Consequently, it is 
possible to postulate that OS plays a central role in the regulation of intestinal Mrp2 
expression under MetS conditions. Whether vitamin C corrected also, directly or 
indirectly, the inflammatory response was not explored in this study. However, this 
possibility should not be ruled out since, as was mentioned above, the sequential link 
between a fructose-rich diet, OS and inflammatory response has been largely 
demonstrated [61-63]. Even more, recent studies had revealed anti-inflammatory 
properties of vitamin C, whose mechanism have been attributed to its ability to 
modulate NF-ĸB-DNA binding activity and down-regulate hepatic mRNA expression of 
TNF- and IL-6, among other actions [64-66]. Clearly, more direct studies are 
necessary to elucidate to what extent OS or inflammation is responsible for down-
regulation of intestinal Mrp2. 
In conclusion, we demonstrate for the first time that geraniol or vitamin C 
administration can completely revert down-regulation of intestinal Mrp2 in fructose-fed 
rats, strongly suggesting that OS and the inflammatory response are critical factors 
leading to the impairment of Mrp2 function. Our study suggests that modulation of 
Mrp2, as a relevant member of the intestinal transcellular barrier that conditions drug 
bioavailability and xenobiotics toxicity, represent an additional beneficial effect of 
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Fig. 1: Schematic representation of treatment protocols 
Two treatment protocols were used, named: A, Protocol of reversion by geraniol 
(Groups: C, FRU, GO, and FRU+GO; n6-8), and B, Protocol of reversion by vitamin 
C (Groups: C, FRU, GO, and FRU+VitC; n6-12). The duration of both protocols was 
35 days in total. The initial 21 days correspond to the installation of Mets, which was 
verified by plasma TAG (triacylclicerol) and inmunoreactive insulin levels, and by the 
intraperitoneal glucose tolerance test (IPGTT). Treatment with geraniol and vitamin C 
was initiated at day 22, while fructose administration was maintained. Animals were 
fasted 12 hours before sample collection. 
 
Fig. 2. Effect of geraniol on glucose homeostasis 
Response curves during the intraperitoneal glucose tolerance (IPGTT) (A) and insulin 
tolerance (ITT) (B) tests. Serum glucose concentrations under IPGTT and ITT 
conditions are shown in mM (mmol/L). Inserts depict quantification of cumulative 
glucose clearance in the IPGTT and the ITT by integration of the area under the curve 
(AUC), in mM/120 min or mM/90 min respectively. 
Data are expressed as means±S.D. of 6 rats per group. 
*, significantly different from C, GO and FRU+GO, P < 0.05.  
 
Fig. 3: Effect of geraniol on Mrp2 down-regulation induced by fructose 
administration 
A, Western blot analysis of Mrp2 in BBM vesicles from proximal jejunum. Equal 
amounts of total protein (20 µg) were loaded in all lanes. Uniformity of loading and 
transfer from gel to nitrocellulose membrane was controlled with Ponceau S and 
detection of β-actin. Densitometry data were related to β-actin and presented as % of 
controls (C). B, Quantitative real-time PCR assessment of ABCC2 mRNA levels in 
proximal jejunum. Results were referred to 18s rRNA and expressed as % of controls 
(C). C, Cumulative content of DNP-SG in the mucosal compartment of everted 
intestinal sacs at 30 min of incubation. Results were expressed as % of controls (C). 
Data are expressed as means±S.D. of 6 to 8 rats per group. 

















Fig. 4: Effect of geraniol on altered intestinal redox balance and anti-oxidant 
defenses induced by fructose administration 
GSH/GSSG ratio (A), thiobarbituric acid reactive substances (TBARS) (B), superoxide 
dismutase (SOD) activity (C), and catalase (CAT) activity (D) were determined in 
intestinal homogenate of rats from C, FRU, GO and FRU + GO groups. All results were 
expressed as % of controls (C). 
Data are expressed as means±S.D. of 6 to 8 rats per group. 
*, significantly different from C, GO and FRU+GO, P< 0.05. 
&
, significantly different from C, P<0.05. 
 
Fig. 5: Effect of geraniol on increased intestinal proinflammatory cytokine levels 
induced by fructose administration 
Interleukin1β (IL-1β) (A) and interleukin 6 (IL-6) (B) were determined in intestinal 
homogenate of rats from C, FRU, GO and FRU + GO groups. All results were 
expressed as % of controls (C). 
Data are expressed as means±S.D. of 6 to 8 rats per group. 
ω
, significantly different from C and FRU+GO, P< 0.05. 
&
, significantly different from C, P<0.05. 
 
Fig. 6. Effect of vitamin C on glucose homeostasis 
Response curves during the intraperitoneal glucose tolerance (IPGTT) (A) and insulin 
tolerance (ITT) (B) tests. Serum glucose concentrations under IPGTT and ITT 
conditions are shown in mM (mmol/L). Inserts depict quantification of cumulative 
glucose clearance in the IPGTT and the ITT by integration of the area under the curve 
(AUC), in mM/120 min or mM/90 min respectively. 
Data are expressed as means±S.D. of 6 rats per group. 
#
, significantly different from C, VitC and FRU+VitC, P < 0.05. 
 
Fig.7: Effect of vitamin C on Mrp2 down-regulation induced by fructose 
administration 
A, Western blot analysis of Mrp2 in BBM vesicles from proximal jejunum. Equal 
















transfer from gel to nitrocellulose membrane was controlled with Ponceau S and 
detection of β-actin. Densitometry data were related to β-actin and presented as % of 
controls (C). B, Quantitative real-time PCR assessment of Mrp2 mRNA levels in 
proximal jejunum. Results were referred to 18s rRNA and expressed as % of controls 
(C). C, Cumulative content of DNP-SG in the mucosal compartment of everted 
intestinal sacs after 30 min of incubation. Results were expressed as % of controls (C). 
Data are expressed as means±S.D. of 10 to 12 rats per group. 
#
, significantly different from C, VitC and FRU+VitC, P < 0.05. 
 
Fig. 8: Effect of vitamin C on altered intestinal redox balance and anti-oxidant 
defenses induced by fructose administration 
GSH/GSSG ratio (A), thiobarbituric acid reactive substances (TBARS) (B), superoxide 
dismutase (SOD) activity (C), and catalase (CAT) activity (D) were determined in 
intestinal homogenate of rats from C, FRU, VitC and FRU + VitC groups. All results 
were expressed as % of controls (C). 
Data are expressed as means±S.D. of 10 to 12 rats per group. 
#
, significantly different from C, VitC and FRU+VitC, P< 0.05. 
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Table 1. Serum markers of MetS 
 C FRU GO FRU+GO 
Plasma glucose (mmol/l)  5,71 ± 0,44 6,21 ± 0,50 5,27± 0,72 5,44± 0,11 
Plasma triglycerides(mmol/l) 0,98 ± 0,09 1,40 ± 0,08* 0,72± 0,17 0,94± 0,06 
Plasma insulin (ng/ml) 1,24 ± 0,12 2,58 ± 0,37* 1,16± 0,36 1,21 ± 0,12 
HOMA-IR 5,85 ± 3,82 14,81 ± 6,67* 6,60 ± 1,19 6,78± 0,92 
     
The HOMA-IR was calculated with the formula: serum insulin (µUI/ml)×fasting blood 
glucose (mmol/l)/22.5. An increment in the HOMA–IR index indicates an insulin 
resistance state in FRU rats. 
Data are expressed as means±S.D. of 6 to 8 rats per group. 
*, significantly different from C, GO and FRU+GO, P < 0.05.  
 
Table 2. Serum markers of MetS 
 C FRU VitC FRU+VitC 
Plasma glucose (mmol/l)  5,38 ± 0,77 5,51 ± 0,19 5,15 ± 0,16 5,35 ± 0,09 
Plasma triglycerides(mmol/l) 0,95 ± 0,11 1,34 ± 0,29
#
 0,64 ± 0,04 0,91 ± 0,09 
Plasma insulin (ng/ml) 1,58 ± 0,18 3,10 ± 0,34
#
 1,58 ± 0,12 1,78 ± 0,18 
HOMA-IR 5,46 ± 1,20 9,20 ± 1,78
#
 4,79 ± 0,48 6,30 ± 1,28 
     
The HOMA-IR was calculated with the formula: serum insulin (µUI/ml)×fasting blood 
glucose (mmol/l)/22.5. An increment in the HOMA–IR index indicates an insulin 
resistance state in FRU rats. 
Data are expressed as means±S.D. of 6 to 8 rats per group. 
#
, significantly different from C, VitC and FRU+VitC, P < 0.05. 
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